Informational only — Not medical advice. Always consult a licensed healthcare provider.

Community data Updated 2 months ago

Indications

This eye drop is indicated for the symptomatic treatment of allergic conjunctivitis.

⚠️ Always consult a registered physician before taking any medicine.

Pharmacology

This ophthalmic solution combines Naphazoline Hydrochloride and Pheniramine Maleate, bringing together the effects of an antihistamine and a decongestant in a single preparation. Pheniramine Maleate is the antihistamine component, while Naphazoline Hydrochloride serves as the decongestant. Naphazoline Hydrochloride is a direct acting sympathomimetic amine that acts on alpha adrenergic receptors in the arterioles of the conjunctiva to produce vasoconstriction, thereby reducing conjunctival congestion. Pheniramine Maleate is an alkylamine derivative with antimuscarinic and central sedative properties, used to relieve the symptoms of hypersensitivity reactions such as conjunctivitis.

Pregnancy & Breastfeeding

Pregnancy category C. There are no or a limited amount of data from the use of topical ophthalmic Naphazoiine or Pheniramine in pregnant women. It should only be used by a pregnant woman if clearly needed. There are no well-controlled studies in breast-feeding women. It should only be used by a breast-feeding woman if clearly needed.

⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.

Dosage Reference

⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.

Adults: Instill one to two drops into the affected eye(s), three to four times a day. This medicine has not been established as safe or effective for children under 6 years of age.